NEW YORK (GenomeWeb) – Genomics Ltd. has raised £10.3 million ($12.8 million) in a private round of financing, according to a statement released today by one of its investors, the IP Group.

The firm, which is a spinout from the University of Oxford in the UK, is developing a platform for genomic sequence data analysis. Its founders include Oxford Professors Peter Donnelly, who also is director of the Wellcome Trust Centre for Human Genetics, and Gil McVean. It is chaired by David Norwood, who was one of the founders of Oxford Nanopore Technologies.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The United Nations is to consider a ban on field testing gene drives at a meeting being held next week, Technology Review reports.

The Associated Press reports that gene-edited food may soon be for sale.

The US Department of Health and Human Services is beginning a series of meetings on human fetal tissue research, Stat News reports.

In Cell this week: epigenetic change linked to glioblastomas, rare and low-frequency variants contributing to multiple sclerosis risk, and more.